Infrared Brain Therapy

COVID-19 outbreaks have caused a global health crisis, resulting in millions of deaths and diagnoses. Long-term new crown outbreaks are a state in which patients continue to experience symptoms even after recovering from COVID-19, which is estimated to affect 76% of COVID-19 cases six months after the initial infection.

Neurological symptoms are common in patients with COVID-19, including headaches, confusion, and loss of smell and taste. Researchers are studying the effectiveness of cranial photobiomodulation (tPBM), a therapy that uses light to stimulate brain cells, on the neurological symptoms of patients with COVID-19 and long-term COVID. tPBM is a treatment that uses light to stimulate brain cells.

What’s the technical parameter of the COZING-C320 infrared brain therapy?

Mechanism of 1050nm Red Light LED Therapy for COVID-19 Treatment

Photobiomodulation Therapy (PBMT) using 1050nm red/infrared light modulates immune response, reduces inflammation, and enhances tissue repair, aiding COVID-19 recovery through multiple biological pathways.

1. Suppresses Hyperinflammation (Cytokine Storm Modulation)

Mechanism:

1050nm light is absorbed by mitochondrial cytochrome c oxidase (CCO), reducing reactive oxygen species (ROS) and oxidative stress.

2. Improves Lung Function & Oxygenation

Mechanism:

1050nm light penetrates 5-7cm deep, reaching alveoli and bronchial tissues, promoting vasodilation (via NO release) and microcirculation.

Enhances hemoglobin oxygen affinity, improving blood oxygen saturation (SpO₂).

3. Restores ACE2 Receptor Homeostasis

Mechanism:

SARS-CoV-2 downregulates ACE2 receptors, causing angiotensin-II accumulation (worsening lung injury).

1050nm light balances ACE2/AT1R expression, reducing vascular permeability and mitigating acute respiratory distress syndrome (ARDS).

4. Boosts Immune Cell Activity

Mechanism:

Increases mitochondrial ATP production in T cells and NK cells, enhancing viral clearance.

5. Repairs Tissue Damage (Anti-Fibrotic Effect)

Mechanism:

Inhibits TGF-β pathway, reducing pulmonary fibrosis risk.

Stimulates collagen remodeling by fibroblasts, repairing alveolar damage.

1.High-Density LED Coverage

320 medical-grade LEDs with 1050nm wavelength for optimal scalp penetration

Simultaneously treats 12 scalp zones for full-head coverage

2.Precision Frequency Control

Adjustable 1-20,000Hz modulation (scientifically tuned for follicle activation)

Customizable protocols for different hair loss stages

3..Smart Treatment System

Wireless remote control for easy operation

Auto-session tracking with memory function

4.Clinical-Grade Efficacy

1050nm wavelength boosts ATP production 3x vs standard 650nm devices

Stimulates dormant follicles while reducing DHT sensitivity

5.User-Centric Design

Ultra-lightweight with ergonomic weight distribution

Silent operation (<30dB) for comfortable home/office use

OVERVIEW

It is increasingly recognized that COVID-19 sequelae include chronic fatigue and brain fog, and photobiomodulation (PBM) therapies have been used to treat these conditions. This open-label, pilot human clinical study examined the effects of two PBM devices, such as a helmet (1050 nm COZING-C320) for cranial (tPBM) over a 4-week period, with 12 treatments (n = 7 per group) performed in two separate groups. Before and after treatment, subjects were assessed using a battery of neuropsychological tests including the Montreal Cognitive Assessment (MoCA), Digit Symbol Substitution Test (DSST), Connectivity Tests A and B, Physical Reaction Time (PRT), and a quantitative EEG system (WAVi). Each device used for PBM delivery was associated with significant improvements in cognitive testing (p < 0.05 and above.) Changes in WAVi supported this finding. This study outlines the benefits of utilizing PBM therapy (transcranial ) to help treat long-term COVID brain fog.

Procedure

Participants received three treatments per week (48 hours between treatments) for 4 weeks. Group 1 received tPBM; Group 2 received COZING-C320. tPBM treatments were administered using a COZING-C320 1050nm light-emitting diode (LED) helmet. The helmet was lined with LEDs emitting photons at a wavelength of 1050 nm (100% duty cycle, CW), with a tissue surface irradiance (power density) of 24 mW/cm 2 for 14 minutes, an energy density of 20.2 J/cm 2, and a photon energy density of 24.2 pJ/cm 2 and 5.4 Einstein. Based on the reported surface area of the scalp (650 cm 2 ) As a proof-of-principle study, the design used only active treatments. Subjects were randomly assigned to receive PBM treatments using a digital randomization procedure.

Results.

Of the 16 subjects initially recruited, one subject failed to receive testing and treatment. Another subject withdrew from the study after one session because she was unable to participate in the repeat treatment and evaluation program.Fourteen subjects completed all evaluations and treatments, 10 females and 4 males, ranging in age from 37 to 42 years, with a median age of 56 years, and an equal number of subjects treated with PBM (7 each). All subjects reported improvement in symptoms and did not experience any adverse events (either anticipated or unexpected) during the course of the study

Hot Tags: infrared brain therapy, China infrared brain therapy manufacturers, suppliers, factory, light therapy for brain, laser photobiomodulation therapy, photo bio modulation therapy, photobiomodulation brain, brain light therapy device, red light therapy device for brain